Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Video game training enhances cognitive control in older adults.
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Tysabri
High-field imaging of neurodegenerative diseases.
Estimation of the effect of dalfampridine on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Microvesicles: novel biomarkers for neurological disorders.
Chronic inflammatory demyelinating polyneuropathy following malignant melanoma.
Benign Multiple Sclerosis: Does it exist?
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)
Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Lodonal/LDN
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis.
Pages
« first
‹ previous
…
111
112
113
114
115
116
117
118
119
…
next ›
last »